Evidence map›Paper›PMID 30878597›Full record

ArticleEBioMedicine2019

STING-mediated intestinal barrier dysfunction contributes to lethal sepsis.

Qiongyuan Hu, Huajian Ren, Guanwei Li, Dingyu Wang, Quan Zhou, Jie Wu, Jiashuo Zheng, Jinjian Huang, Dominic A Slade, Xiuwen Wu and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 231 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Qiongyuan HuResearch Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China; Medical School of Nanjing University, Nanjing, China.
Huajian RenResearch Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Guanwei LiDepartment of colorectal and anal surgery, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, China.
Dingyu WangMedical School of Nanjing University, Nanjing, China; State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animal for Disease Study, Collaborative Innovation Center of Genetics and Development, Model Animal Research Center, Nanjing, China.
Quan ZhouMedical School of Nanjing University, Nanjing, China.
Jie WuResearch Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China; Medical School of Nanjing University, Nanjing, China.
Jiashuo ZhengResearch Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China; Medical School of Nanjing University, Nanjing, China.
Jinjian HuangResearch Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China.
Dominic A SladeMedical School of Nanjing University, Nanjing, China; Department of Surgery, Salford Royal NHS Foundation Trust, Stott Lane, Salford, United Kingdom. Electronic address: dom.slade@talktalk.net.
Xiuwen WuResearch Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. Electronic address: lygwxw@163.com.
Jianan RenResearch Institute of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing, China. Electronic address: JiananR@gmail.com.
Nanjing General Hospital of Nanjing Military Command · CNGuangzhou First People's Hospital · CNModel Animal Research Center · CNNanjing Medical University · CNSalford Royal NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGut integrity is compromised in abdominal sepsis with increased cellular apoptosis and altered barrier permeability. Intestinal epithelial cells (IEC) form a physiochemical barrier that separates the intestinal lumen from the host's internal milieu and is strongly involved in the mucosal inflammatory response and immune response. Recent research indicates the involvement of the stimulator of interferons genes (STING) pathway in uncontrolled inflammation and gut mucosal immune response.

methodsWe investigated the role of STING signaling in sepsis and intestinal barrier function using intestinal biopsies from human patients with abdominal sepsis and with an established model of abdominal sepsis in mice.

findingsIn human abdominal sepsis, STING expression was elevated in peripheral blood mononuclear cells and intestinal biopsies compared with healthy controls, and the degree of STING expression in the human intestinal lamina propria correlated with the intestinal inflammation in septic patients. Moreover, elevated STING expression was associated with high levels of serum intestinal fatty acid binding protein that served as a marker of enterocyte damage. In mice, the intestinal STING signaling pathway was markedly activated following the induction of sepsis induced by cecal ligation perforation (CLP). STING knockout mice showed an alleviated inflammatory response, attenuated gut permeability, and decreased bacterial translocation. Whereas mice treated with a STING agonist (DMXAA) following CLP developed greater intestinal apoptosis and a more severe systemic inflammatory response. We demonstrated that mitochondrial DNA (mtDNA) was released during sepsis, inducing the intestinal inflammatory response through activating the STING pathway. We finally investigated DNase I administration at 5 hours post CLP surgery, showing that it reduced systemic mtDNA and inflammatory cytokines levels, organ damage, and bacterial translocation, suggesting that inhibition of mtDNA-STING signaling pathway protects against CLP-induced intestinal barrier dysfunction.

interpretationOur results indicate that the STING signaling pathway can contribute to lethal sepsis by promoting IEC apoptosis and through disrupting the intestinal barrier. Our findings suggest that regulation of the mtDNA-STING pathway may be a promising therapeutic strategy to promote mucosal healing and protect the intestinal barrier in septic patients. FUND: National Natural Science Foundation of China.

Indexed as

AnimalsApoptosisBacteriaCytokinesDendritic CellsDisease Models, AnimalDNA, MitochondrialEpithelial CellsHumansInterferon Regulatory Factor-3Intestinal MucosaIntestinesLeukocytes, MononuclearMembrane ProteinsMiceMice, Inbred C57BLCytokinesDNA, MitochondrialInterferon Regulatory Factor-3IRF3 protein, humanMembrane ProteinsNF-kappa BvadimezanXanthonesIEC apoptosisIntestinal inflammationSepsisSTING

Identifiers

PMID30878597
PMCPMC6443583
OpenAlexW2921822951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.